Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non‐diabetic exosomes <i>in vitro</i>

Sean M. Davidson(University College London), Derek M. Yellon(Royal London Hospital)
Journal of Cellular and Molecular Medicine
August 25, 2017
Cited by 104


Related Papers